<b>Conclusions:</b> In EGFR-mutant NSCLC treated with EGFR-TKIs, TP53 functional domain involvement provides prognostic information beyond TP53 mutation status alone. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.